Austell Pharmaceuticals starts as a new distributor of Biohit Oyj’s GastroPanel[®] test in South Africa
Biohit Oyj Press release 8th April 2021 at 13.00 local time (EET) Biohit Oyj and Austell Pharmaceuticals have signed an agreement for the distribution of the Biohit GastroPanel® test in South Africa. Austell Pharmaceuticals is a private owned South African company. It has been the fastest growing pharma company in South Africa for the past 5 years. Austell’s CEO Suhail Gani: Austell Pharmaceuticals is indeed pleased to have reached an agreement with Biohit Oyj (Finland) for the rights to distribute the GastroPanel® test in South Africa. The GastroPanel® test has been validated